Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $16.79, but opened at $16.16. Sysmex shares last traded at $16.38, with a volume of 1,421 shares.
Sysmex Stock Performance
The company has a market capitalization of $10.43 billion, a P/E ratio of 29.59 and a beta of 1.14. The stock has a fifty day simple moving average of $16.96 and a 200-day simple moving average of $18.00. The company has a quick ratio of 2.30, a current ratio of 2.97 and a debt-to-equity ratio of 0.12.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). Sysmex had a net margin of 10.56% and a return on equity of 11.81%. The business had revenue of $958.89 million during the quarter, compared to analyst estimates of $991.22 million. Equities analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Read More
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.